[ad_1]
Presentation and Q&A consultation scheduled for post-market on Tuesday, November 12, 2024
BOSTON, Nov. 5, 2024 /PRNewswire/ — Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, “Ginkgo”), which is construction the eminent platform for mobile programming and biosecurity, nowadays introduced that it plans to host a presentation and Q&A consultation reviewing trade efficiency for the 3rd quarter ended September 30, 2024, on Tuesday, November 12, 2024, starting at 5:30 p.m. ET.
The presentation main points and webcast hyperlink will likely be to be had on Ginkgo’s investor family members site at https://investors.ginkgobioworks.com, and a replay will likely be made to be had.
To invite a query forward of the presentation, please put up them to @Ginkgo on X (hashtag #GinkgoResults) or through sending an email to [email protected].
About Ginkgo Bioworks
Ginkgo Bioworks is the eminent horizontal platform for mobile programming, offering versatile, end-to-end products and services that resolve demanding situations for organizations throughout various markets, from meals and agriculture to prescription drugs to business and forte chemical substances. Ginkgo Biosecurity is construction and deploying the next-generation infrastructure and applied sciences that world leaders want to are expecting, stumble on, and reply to all kinds of organic warnings. For more info, consult with ginkgobioworks.com and ginkgobiosecurity.com, learn our blog, or practice us on social media channels similar to X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Strings (@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
SOURCE Ginkgo Bioworks
WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Virtual Media
Retailers
270k+
Newshounds
Opted In
[ad_2]
Source link
